Adaptin Bio (APTN) Return on Assets (2024 - 2026)

Adaptin Bio (APTN) has 3 years of Return on Assets data on file, last reported at 0.09% in Q1 2026.

• For the quarter ending Q1 2026, Return on Assets fell 6.0% year-over-year to 0.09%; the trailing twelve-month figure through Mar 2026 stood at 0.09% (down 6.0% YoY), and the FY2025 full-year result was 0.1%, up 11.0% from the prior year.
• Return on Assets fell to 0.09% in Q1 2026, from 0.06% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.02% in Q2 2025 to a low of 72.53% in Q3 2024.
• A 3-year average of 13.46% and a median of 0.09% in 2026 frame the typical range for Return on Assets.
• Across the five-year window, Return on Assets soared 7249 bps in 2025 and decreased 6 bps in 2026, its largest moves.
• Tracing APTN's Return on Assets over 3 years: stood at 0.26% in 2024, then jumped by 75 bps to 0.06% in 2025, then tumbled by 33 bps to 0.09% in 2026.
• Business Quant data shows APTN's Return on Assets at 0.09% in Q1 2026, 0.06% in Q4 2025, and 0.04% in Q3 2025.